P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY

por Renaud, L., Stéphan, P., durand, S., Escure, G., Franck, M., camus, V., tilly, H., casasnovas, O., Chevret, S., Thieblemont, C.
Publicado 2022

Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.

por Morel, P., Dupriez, B., Herbrecht, R., Bastion, Y., Tilly, H., Delannoy, A., Haioun, C., Nouvel, C., Bouabdallah, K., Baumelou, E.
Publicado 1994

Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11)

por Chamseddine, A. N., Etancelin, P., Penther, D., Parmentier, F., Kuadjovi, C., Camus, V., Contentin, N., Lenain, P., Bastard, C., Tilly, H., Jardin, F.
Publicado 2015

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

por Zinzani, P. L., Vose, J. M., Czuczman, M. S., Reeder, C. B., Haioun, C., Polikoff, J., Tilly, H., Zhang, L., Prandi, K., Li, J., Witzig, T. E.
Publicado 2013

P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L...

por McMillan, A., Haioun, C., Sancho, J.-M., Viardot, A., Rodriguez Izquierdo, A., Donato Martin, E. M., García-Sancho, A. M., Sandoval-Sus, J., Tilly, H., Vandenberghe, E., Hirata, J., Choudhry, P., Chang, Y. M., Musick, L., Matasar, M.
Publicado 2022

P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL

por Song, Y., Jin, J., Tilly, H., Zhang, H., Cao, J., Feng, J., Zhang, L., Rai, S., Goto, H., Terui, Y., Kim, W. S., Shin, H.-J., Gau, J.-P., Tsai, C.-H., Sharman, J. P., Bu, L., Hirata, J., Lee, C., Izutsu, K., Zhu, J.
Publicado 2022

P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY

por Trněný, M., Fogliatto, L., Gardner, F., Flinn, I., Larouche, J.-F., Haioun, C., Canales, M., Goto, H., Hajek, R., Salles, G., Qiu, J., Campinha-Bacote, A., Yan, M., Kothari, R., Man, G., Sahin, D., Hirata, J., Lee, C., Tilly, H., Flowers, C.
Publicado 2022

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II...

por Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.-M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.-M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.
Publicado 2022